These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

466 related items for PubMed ID: 31462571

  • 1. Disruption of Type III Interferon (IFN) Genes Ifnl2 and Ifnl3 Recapitulates Loss of the Type III IFN Receptor in the Mucosal Antiviral Response.
    Peterson ST, Kennedy EA, Brigleb PH, Taylor GM, Urbanek K, Bricker TL, Lee S, Shin H, Dermody TS, Boon ACM, Baldridge MT.
    J Virol; 2019 Nov 15; 93(22):. PubMed ID: 31462571
    [Abstract] [Full Text] [Related]

  • 2. Expression of Ifnlr1 on Intestinal Epithelial Cells Is Critical to the Antiviral Effects of Interferon Lambda against Norovirus and Reovirus.
    Baldridge MT, Lee S, Brown JJ, McAllister N, Urbanek K, Dermody TS, Nice TJ, Virgin HW.
    J Virol; 2017 Apr 01; 91(7):. PubMed ID: 28077655
    [Abstract] [Full Text] [Related]

  • 3. Epigenetic Suppression of Interferon Lambda Receptor Expression Leads to Enhanced Human Norovirus Replication In Vitro.
    Arthur SE, Sorgeloos F, Hosmillo M, Goodfellow IG.
    mBio; 2019 Oct 01; 10(5):. PubMed ID: 31575769
    [Abstract] [Full Text] [Related]

  • 4. HOIL1 Is Essential for the Induction of Type I and III Interferons by MDA5 and Regulates Persistent Murine Norovirus Infection.
    MacDuff DA, Baldridge MT, Qaqish AM, Nice TJ, Darbandi AD, Hartley VL, Peterson ST, Miner JJ, Iwai K, Virgin HW.
    J Virol; 2018 Dec 01; 92(23):. PubMed ID: 30209176
    [Abstract] [Full Text] [Related]

  • 5. Type III interferon drives pathogenicity to Staphylococcus aureus via the airway epithelium.
    Pires S, Kaiser K, Parker D.
    mBio; 2024 Jul 17; 15(7):e0113024. PubMed ID: 38934617
    [Abstract] [Full Text] [Related]

  • 6. The TLR3/IRF1/Type III IFN Axis Facilitates Antiviral Responses against Enterovirus Infections in the Intestine.
    Su R, Shereen MA, Zeng X, Liang Y, Li W, Ruan Z, Li Y, Liu W, Liu Y, Wu K, Luo Z, Wu J.
    mBio; 2020 Nov 17; 11(6):. PubMed ID: 33203755
    [Abstract] [Full Text] [Related]

  • 7. Differential expression of interferon-lambda receptor 1 splice variants determines the magnitude of the antiviral response induced by interferon-lambda 3 in human immune cells.
    Santer DM, Minty GES, Golec DP, Lu J, May J, Namdar A, Shah J, Elahi S, Proud D, Joyce M, Tyrrell DL, Houghton M.
    PLoS Pathog; 2020 Apr 17; 16(4):e1008515. PubMed ID: 32353085
    [Abstract] [Full Text] [Related]

  • 8. Interferon Lambda Signaling in Macrophages Is Necessary for the Antiviral Response to Influenza.
    Mallampalli RK, Adair J, Elhance A, Farkas D, Chafin L, Long ME, De M, Mora AL, Rojas M, Peters V, Bednash JS, Tsai M, Londino JD.
    Front Immunol; 2021 Apr 17; 12():735576. PubMed ID: 34899695
    [Abstract] [Full Text] [Related]

  • 9. Type I and Type III Interferons Differ in Their Adjuvant Activities for Influenza Vaccines.
    Ye L, Ohnemus A, Ong LC, Gad HH, Hartmann R, Lycke N, Staeheli P.
    J Virol; 2019 Dec 01; 93(23):. PubMed ID: 31511392
    [Abstract] [Full Text] [Related]

  • 10. Influence of Canonical and Non-Canonical IFNLR1 Isoform Expression on Interferon Lambda Signaling.
    Evans JG, Novotny LA, Meissner EG.
    Viruses; 2023 Feb 25; 15(3):. PubMed ID: 36992341
    [Abstract] [Full Text] [Related]

  • 11. Expression of Interferons Lambda 3 and 4 Induces Identical Response in Human Liver Cell Lines Depending Exclusively on Canonical Signaling.
    Lunova M, Kubovciak J, Smolková B, Uzhytchak M, Michalova K, Dejneka A, Strnad P, Lunov O, Jirsa M.
    Int J Mol Sci; 2021 Mar 04; 22(5):. PubMed ID: 33806448
    [Abstract] [Full Text] [Related]

  • 12. Type III Interferon-Mediated Signaling Is Critical for Controlling Live Attenuated Yellow Fever Virus Infection In Vivo.
    Douam F, Soto Albrecht YE, Hrebikova G, Sadimin E, Davidson C, Kotenko SV, Ploss A.
    mBio; 2017 Aug 15; 8(4):. PubMed ID: 28811340
    [Abstract] [Full Text] [Related]

  • 13. Lambda interferon is the predominant interferon induced by influenza A virus infection in vivo.
    Jewell NA, Cline T, Mertz SE, Smirnov SV, Flaño E, Schindler C, Grieves JL, Durbin RK, Kotenko SV, Durbin JE.
    J Virol; 2010 Nov 15; 84(21):11515-22. PubMed ID: 20739515
    [Abstract] [Full Text] [Related]

  • 14. Interferon lambda restricts herpes simplex virus skin disease by suppressing neutrophil-mediated pathology.
    Philip DT, Goins NM, Catanzaro NJ, Misumi I, Whitmire JK, Atkins HM, Lazear HM.
    mBio; 2024 Apr 10; 15(4):e0262323. PubMed ID: 38426749
    [Abstract] [Full Text] [Related]

  • 15. Antiviral activity of bovine type III interferon against bovine viral diarrhea virus is greatly reduced in bovine turbinate cells due to limited expression of IFN lambda receptor 1 (IL-28Rα).
    Dassanayake RP, Menghwar H, Bickel KA, Holthausen DJ, Ma H, Diaz-San Segunda F, Rodriguez-Calzada M, Medina GN, Attreed S, Falkenberg SM, Kanipe C, Sacco RE, De Los Santos T, Casas E.
    Front Immunol; 2024 Apr 10; 15():1441908. PubMed ID: 39224597
    [Abstract] [Full Text] [Related]

  • 16. Type I and III interferons disrupt lung epithelial repair during recovery from viral infection.
    Major J, Crotta S, Llorian M, McCabe TM, Gad HH, Priestnall SL, Hartmann R, Wack A.
    Science; 2020 Aug 07; 369(6504):712-717. PubMed ID: 32527928
    [Abstract] [Full Text] [Related]

  • 17. IFN-λ Decreases Murid Herpesvirus-4 Infection of the Olfactory Epithelium but Fails to Prevent Virus Reactivation in the Vaginal Mucosa.
    Jacobs S, Zeippen C, Wavreil F, Gillet L, Michiels T.
    Viruses; 2019 Aug 16; 11(8):. PubMed ID: 31426334
    [Abstract] [Full Text] [Related]

  • 18. Lambda interferon (IFN-lambda), a type III IFN, is induced by viruses and IFNs and displays potent antiviral activity against select virus infections in vivo.
    Ank N, West H, Bartholdy C, Eriksson K, Thomsen AR, Paludan SR.
    J Virol; 2006 May 16; 80(9):4501-9. PubMed ID: 16611910
    [Abstract] [Full Text] [Related]

  • 19. Interferon-λ restricts West Nile virus neuroinvasion by tightening the blood-brain barrier.
    Lazear HM, Daniels BP, Pinto AK, Huang AC, Vick SC, Doyle SE, Gale M, Klein RS, Diamond MS.
    Sci Transl Med; 2015 Apr 22; 7(284):284ra59. PubMed ID: 25904743
    [Abstract] [Full Text] [Related]

  • 20. Type III Interferons in Viral Infection and Antiviral Immunity.
    Zhou JH, Wang YN, Chang QY, Ma P, Hu Y, Cao X.
    Cell Physiol Biochem; 2018 Apr 22; 51(1):173-185. PubMed ID: 30439714
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.